Nicola Biagio Mercuri
Nicola Biagio Mercuri is an expert in Neurology at Fondazione Santa Lucia (Italy). As of July 2026, ScienceLeadR ranks Nicola Biagio Mercuri in the top 1% of experts worldwide for Parkinson Disease, Basal Ganglia Diseases and Neurocognitive Disorders. Nicola Biagio Mercuri has authored 678 publications, the most recent in 2026. SLR score: 1,909 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Sleep Medicine Specialty - Biochemistry - Psychiatry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1987 - 2026
Number : 678
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Altered brain glucose metabolism and connectivity in young adults with obstructive sleep apnea. PMID 42363277 — eye, dementia, frontal lobe, sleep apnea, obstructive, alzheimer disease, sleep, positron-emission tomography, brain, apnea, polysomnography, cerebellum, parietal lobe, eye movements, sleep apnea syndromes, movement, cognition | Alzheimers Dement | 2026 | 0 |
| Comparative efficacy of agomelatine and escitalopram in people with epilepsy and comorbid major depressive disorder: A double-blind randomized controlled trial. PMID 42327517 — epilepsy, sleep, depressive disorder, drug-related side effects and adverse reactions, seizures, depressive disorder, major | Epilepsy Behav Rep | 2026 | 0 |
| Lateralization of interictal epileptiform discharges differently impacts cognitive performance and behavior in late-onset epilepsy of unknown aetiology. PMID 42293148 — quality of life, epilepsy, sleep | Front Aging Neurosci | 2026 | 0 |
| Do animal models represent the diversity of clinical Parkinson's disease? PMID 42191412 — parkinson disease, neurobiology | Curr Opin Neurobiol | 2026 | 0 |
| Cell Cycle Dysfunction and Metabolic Alterations Consistent With Pathological Tau in Progressive Supranuclear Palsy Derived Fibroblasts. PMID 42120786 — cells, supranuclear palsy, progressive, neurobiology, fibroblasts, paralysis, neurodegenerative diseases, cell cycle | Mol Neurobiol | 2026 | 0 |
LeadR Networks
Main global connection map